Tubulis

About:

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

Website: http://tubulis.com

Twitter/X: tubulis_gmbh

Top Investors: Andera Partners, HTGF | High-Tech Gruenderfonds, Evotec, Seventure Partners, Bayern Kapital

Description:

Tubulis develops chemotherapeutic medications to combat cancer and chronic disorders. The company's chemotherapeutic medications are specifically matched protein-drug conjugates created by merging proprietary innovative technology with disease-specific biology, allowing clinicians to treat cancer patients without the risks associated with chemotherapy.

Total Funding Amount:

200M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Munich, Bayern, Germany

Founded Date:

2012-01-01

Contact Email:

info(AT)tubulis.com

Founders:

Dominik Schumacher, Jonas Helma

Number of Employees:

11-50

Last Funding Date:

2024-03-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai